RT Journal Article
SR Electronic
T1 The cross-sectional area of the vagus nerve is not reduced in Parkinson’s Disease patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.19.20214973
DO 10.1101/2020.10.19.20214973
A1 Laura C.J. Sijben
A1 Werner H. Mess
A1 Uwe Walter
A1 A. Miranda L. Janssen
A1 Mark Kuijf
A1 Mayke Oosterloo
A1 Wim M. Weber
A1 Marcus L.F. Janssen
YR 2020
UL http://medrxiv.org/content/early/2020/10/21/2020.10.19.20214973.abstract
AB Objective Recent studies have revealed the importance of the gut brain axis in the development of Parkinson’s disease (PD). It has also been suggested that the cross-sectional area (CSA) of the vagus nerve can be used in the diagnosis of PD. Here, we hypothesize that the CSA of the vagus nerve is decreased in PD patients compared to control subjects.Methods In this study we measured the CSA of the vagus nerve on both sides in 31 patients with PD and 51 healthy controls at the level of the common carotid artery using high-resolution ultrasound.Results The CSA of the vagus nerve was not reduced in PD patients compared to controls (p = 0.391. The mean CSA of the left vagus nerve was significantly smaller than the right (p < 0.001). There was no significant correlation between age, gender and autonomic symptoms with the CSA of the left (p = 0.128) and right vagus nerve (p = 0.166).Conclusion These findings show that the CSA of the vagus nerve using ultrasonography is not a reliable diagnostic tool in the diagnosis of PD.HighlightsThe cross-sectional area of the vagus nerve is not decreased in Parkinson disease patients.The cross-sectional area of the vagus nerve does not correlate with autonomic symptoms.Measurement of the vagus nerve cross-sectional area has a high inter-observer correlation.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialno prospective studyFunding StatementNo funding sources to report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Local ethical committee (METC Maastricht University Medical Center, the Netherlands approved the study, registered under protocol number 2019-1223All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be requested by email to the corresponding author.